GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » Price-to-Operating-Cash-Flow

Fuan Pharmaceutical (Group) Co (SZSE:300194) Price-to-Operating-Cash-Flow : 9.03 (As of May. 31, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow?

As of today (2024-05-31), Fuan Pharmaceutical (Group) Co's share price is ¥4.08. Fuan Pharmaceutical (Group) Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.45. Hence, Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow Ratio for today is 9.03.

The historical rank and industry rank for Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

SZSE:300194' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.92   Med: 25.36   Max: 578.64
Current: 9.03

During the past 13 years, Fuan Pharmaceutical (Group) Co's highest Price-to-Operating-Cash-Flow Ratio was 578.64. The lowest was 7.92. And the median was 25.36.

SZSE:300194's Price-to-Operating-Cash-Flow is ranked better than
75.33% of 681 companies
in the Drug Manufacturers industry
Industry Median: 16.22 vs SZSE:300194: 9.03

Fuan Pharmaceutical (Group) Co's Cash Flow from Operations per share for the three months ended in Mar. 2024 was ¥0.13. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.45.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Fuan Pharmaceutical (Group) Co was 147.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 24.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.10% per year.

During the past 13 years, Fuan Pharmaceutical (Group) Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 39.80% per year. The lowest was -55.20% per year. And the median was -4.30% per year.


Fuan Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Chart

Fuan Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.98 35.21 23.59 12.77 16.22

Fuan Pharmaceutical (Group) Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.91 14.70 21.17 16.22 8.45

Competitive Comparison of Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow falls into.



Fuan Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Calculation

Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=4.08/0.452
=9.03

Fuan Pharmaceutical (Group) Co's Share Price of today is ¥4.08.
Fuan Pharmaceutical (Group) Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.45.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Fuan Pharmaceutical (Group) Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co (SZSE:300194) Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
Executives
Wu Xiong Hui Executives
Huang Tao Directors, executives
Feng Jing Executives
Yu Xue Song Directors, executives
Hong Rong Chuan Executives
Tang Qin Secretary, Director
Wang Tian Xiang Director
Sun Yong Ping Executives
Jiang Chen Directors, executives
Huang Dao Fei Supervisors
Wen Min Director
Zhou Xu Dong Executives
Zhou Zhong Sheng Supervisors

Fuan Pharmaceutical (Group) Co (SZSE:300194) Headlines

No Headlines